• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.

作者信息

Leake A, Perry E K, Perry R H, Jabeen S, Fairbairn A F, McKeith I G, Ferrier I N

机构信息

MRC Neurochemical Pathology Unit, Newcastle General Hospital, UK.

出版信息

Biol Psychiatry. 1991 Feb 15;29(4):357-64. doi: 10.1016/0006-3223(91)90221-7.

DOI:10.1016/0006-3223(91)90221-7
PMID:1674664
Abstract

Corticotropin releasing hormone (CRH), somatostatin (SRIF), and arginine vasopressin (AVP) concentrations were estimated using radioimmunoassay in the temporal and occipital cortices in postmortem brain from patients clinically and neuropathologically diagnosed as senile dementia of the Lewy body type (SDLT), senile dementia of the Alzheimer type (SDAT), and Parkinson's disease (PD) and from neurologically normal controls. The concentration of temporal and occipital neocortical CRH was diminished in both SDAT and SDLT compared to control values, whereas SRIF was reduced only in temporal cortex in both these conditions. In contrast, the concentrations of both CRH and SRIF were unaltered in PD. The concentrations of AVP in SDLT, SDAT, and PD were similar to those found in the control groups. The decrement in SRIF, but not CRH, was found to be correlated with some indices of severity of illness in SDAT; a similar but nonsignificant trend for SRIF was observed in SDLT.

摘要

相似文献

1
Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
Biol Psychiatry. 1991 Feb 15;29(4):357-64. doi: 10.1016/0006-3223(91)90221-7.
2
Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients.海马体中阿尔茨海默病型病理学的定量神经病理学研究:阿尔茨海默病型老年痴呆症、路易体痴呆症、帕金森病与非痴呆老年对照患者的比较。
J Neurol Sci. 1991 Dec;106(2):142-52. doi: 10.1016/0022-510x(91)90251-2.
3
Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein.路易体痴呆和阿尔茨海默病痴呆在双螺旋丝和过度磷酸化tau蛋白方面存在生物化学差异。
Dementia. 1994 Sep-Oct;5(5):215-28. doi: 10.1159/000106727.
4
Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
J Neurol Sci. 1991 Nov;106(1):50-5. doi: 10.1016/0022-510x(91)90193-b.
5
Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression.
Biol Psychiatry. 1990 Oct 1;28(7):603-8. doi: 10.1016/0006-3223(90)90398-l.
6
Progressive dementia with "diffuse Lewy-type inclusions' in cerebral cortex. A case report.伴有大脑皮质“弥漫性路易体样包涵体”的进行性痴呆。病例报告。
Arch Psychiatr Nervenkr (1970). 1980;228(3):243-8. doi: 10.1007/BF00342349.
7
Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.帕金森病的皮质和皮质下病理学:与帕金森病痴呆的关系
Adv Neurol. 1990;53:35-40.
8
A pathological study of the association between Lewy body disease and Alzheimer's disease.路易体病与阿尔茨海默病关联的病理学研究
J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):701-8. doi: 10.1136/jnnp.52.6.701.
9
Diffuse Lewy body disease: an autopsy case.弥漫性路易体病:一例尸检病例
Acta Med Okayama. 1987 Jun;41(3):133-9. doi: 10.18926/AMO/31770.
10
Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.阿尔茨海默型老年痴呆症患者大脑皮质中精氨酸加压素的减少。
J Neurol Neurosurg Psychiatry. 1987 Jul;50(7):929-32. doi: 10.1136/jnnp.50.7.929.

引用本文的文献

1
Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders.促肾上腺皮质激素释放激素作为帕金森病相关疾病的候选生物标志物。
Brain Commun. 2024 Nov 19;6(6):fcae414. doi: 10.1093/braincomms/fcae414. eCollection 2024.
2
Analysis of microisolated frontal cortex excitatory layer III and V pyramidal neurons reveals a neurodegenerative phenotype in individuals with Down syndrome.分析微分离额皮质兴奋性第 III 和第 V 层的锥体神经元,揭示唐氏综合征个体存在神经退行性表型。
Acta Neuropathol. 2024 Aug 6;148(1):16. doi: 10.1007/s00401-024-02768-0.
3
Multi-Omics Interdisciplinary Research Integration to Accelerate Dementia Biomarker Development (MIRIADE).
多组学跨学科研究整合以加速痴呆生物标志物开发(MIRIADE)。
Front Neurol. 2022 Jul 12;13:890638. doi: 10.3389/fneur.2022.890638. eCollection 2022.
4
Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.帕金森病老年及痴呆患者体内的生长抑素样免疫反应性、其分子形式及单胺能代谢产物——左旋多巴的影响
J Neural Transm (Vienna). 1996;103(5):591-602. doi: 10.1007/BF01273156.
5
Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.衰老与疾病中神经肽的改变。病理生理学及临床干预潜力。
Drugs Aging. 1993 Sep-Oct;3(5):408-27. doi: 10.2165/00002512-199303050-00003.
6
Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophy.显性遗传性橄榄体脑桥小脑萎缩中,大脑皮质生长抑素样免疫反应性浓度降低,但纹状体浓度升高。
J Neurol Neurosurg Psychiatry. 1993 Sep;56(9):1013-5. doi: 10.1136/jnnp.56.9.1013.